Condition (MeSH)
Neoplasm Seeding
ClinicalTrials.gov lists 2 trials for Neoplasm Seeding or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
2 of the 2 trials are tagged with Neoplasm Seeding itself; the rest are tagged with a narrower condition beneath it.
When did Neoplasm Seeding trials start? (2)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
| Year | Trials started |
|---|---|
| 2019 | 1 |
| 2018 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Neoplasm Seeding trials in? (2)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Not applicable | 1 |
How many Neoplasm Seeding trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Neoplasm Seeding? (76)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Tumour Seeding in the Tract of Percutaneous Renal Tumour Biopsy: A Report on Seven Cases from a UK Tertiary Referral Centre. | European urology | 2019 | Yes |
| Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma. | The British journal of ophthalmology | 2018 | Yes |
| Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. | Science (New York, N.Y.) | 2018 | Yes |
| Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. | Science (New York, N.Y.) | 2018 | Yes |
| Potential impact of invasive surgical procedures on primary tumor growth and metastasis. | Clinical & experimental metastasis | 2018 | Yes |
Showing 5 of 76 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.